Pharmaceutical News

RSS

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has approved XIAFLEX (collagenase clostridium histolyticum, or CCH), an in-office, biologic for the treatment of Peyronie's disease. XIAFLEX is the first and only FDA-approved treatment proven effective for PD in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy.

6 Dec 2013

New service helps hospitals and integrated delivery networks expand reach of outpatient pharmacies

At the annual Midyear Clinical Meeting of the American Society of Health-System Pharmacists (ASHP), Cardinal Health will launch a new service that helps hospitals and integrated delivery networks expand the reach of their outpatient pharmacies, while also generating additional revenue and freeing up pharmacist time to drive medication adherence and other quality measures.

6 Dec 2013

Low vitamin D levels: Not a cause but a consequence of ill health

A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson’s disease, and even death.

6 Dec 2013

Women with moderate to severe menstrual cramps may find relief in erectile dysfunction drugs

Women with moderate to severe menstrual cramps may find relief in a class of erectile dysfunction drugs, according to a team of researchers led by Penn State College of Medicines Richard Legro.

6 Dec 2013

Scientists test affected human nerve cells to foretell efficacy of Alzheimer drugs

Why do certain Alzheimer medications work in animal models but not in clinical trials in humans? A research team from the University of Bonn and the biomedical enterprise LIFE & BRAIN GmbH has been able to show that results of established test methods with animal models and cell lines used up until now can hardly be translated to the processes in the human brain. Drug testing should therefore be conducted with human nerve cells, conclude the scientists.

6 Dec 2013

NPS MedicineWise publishes set of FAQs on statins and heart disease

With the statins group of cholesterol-lowering medicines continuing to make headlines this week, independent organisation NPS MedicineWise has reviewed the latest clinical evidence and published a set of Frequently Asked Questions on its website addressing people’s key concerns.

6 Dec 2013

Researchers update extensive toxicology database to track information about drugs toxic effects

Sometimes the cure can be worse than the disease. Pharmaceutical drugs are known for their potential side effects, and an important aspect of personalized medicine is to tailor therapies to individuals to reduce the chances of adverse events.

6 Dec 2013

Revolutionary new treatment for crippling hand conditions

A SELF-EMPLOYED decorator whose crippling hand condition has made it virtually impossible to do the simplest of tasks has had his fingers straightened without the need for surgery, thanks to a revolutionary new treatment.

6 Dec 2013

Study reveals that brain cancer cells resist therapy by dialing down gene mutation targeted by drugs

A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped.

6 Dec 2013

Telomerase inhibiting drug induces morphologic, molecular, clinical remissions in myelofibrosis patients

metelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented today at the 2013 American Society of Hematology Annual Meeting in New Orleans.

6 Dec 2013

Combination of preventive and therapeutic moxibustion has beneficial effect for Alzheimer's disease

An increasing number of clinical and animal studies have confirmed that acupuncture is effective for the treatment of Alzheimer's disease. Moxibustion is reported to be more effective than electro-acupuncture for improving space-recognizing memory ability in aged mice, suggesting that moxibustion is another alternative or complementary therapy used to treat Alzheimer's disease.

6 Dec 2013

Study results show insulin sensitizers reduce risk of cancer in female patients with type 2 diabetes

A Cleveland Clinic-led study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.

5 Dec 2013

Older people ingest too much magnesium, vitamin E in the form of dietary supplements

Many older people are ingesting too much magnesium and vitamin E in the form of dietary supplements. This was discovered by scientists of the Helmholtz Zentrum München in a population-based study; their results have been published in 'The Journal of Nutrition, Health and Aging'.

5 Dec 2013

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Cabergoline Tablets USP, 0.5 mg. Cabergoline Tablets USP are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product.

5 Dec 2013

First Databank starts publishing NADAC pricing file released by CMS

First Databank (FDB), the leading provider of clinical drug knowledge that helps improve medication-related decisions and patient outcomes, today announced it has begun publishing the National Average Drug Acquisition Cost (NADAC) pricing file recently released by The Centers for Medicare & Medicaid Services (CMS).

5 Dec 2013

EMA expands administration options for Hizentra

CSL Behring UK Ltd announced today that the European Medicines Agency (EMA) has expanded the administration options for Hizentra®▼, human normal immunoglobulin, SCIg, 20% liquid, to include dosing once every two weeks (fortnightly).

5 Dec 2013

IDSA released new guideline for vaccination of immunocompromised hosts

A new guideline released Thursday by the Infectious Diseases Society of America (IDSA) notes that most people with compromised immune systems are especially vulnerable to illness and should receive the flu shot and other vaccinations.

5 Dec 2013

VTT receives innovation prize for technological development work behind allergy vaccine

The European Association of Research and Technology Organisations EARTO has awarded VTT Technical Research Centre of Finland an innovation prize for the technological development work behind allergy vaccine.

5 Dec 2013

TB vaccine may help prevent multiple sclerosis

A vaccine used to prevent tuberculosis in other parts of the world may help prevent multiple sclerosis in people who show the beginning signs of the disease, according to a new study published in the December 4, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

5 Dec 2013

MassBiologics gets FDA orphan drug designation for MBL-HCV1 antibody

MassBiologics of the University of Massachusetts Medical School has received an orphan drug designation from the U.S. Food and Drug Administration for MBL-HCV1, a monoclonal antibody developed to prevent hepatitis C virus recurrence in patients receiving a liver transplant.

5 Dec 2013

Pharmaceutical News

Auxilium Pharmaceuticals' XIAFLEX gets FDA approval for treatment of Peyronie's disease

New service helps hospitals and integrated delivery networks expand reach of outpatient pharmacies

Low vitamin D levels: Not a cause but a consequence of ill health

Women with moderate to severe menstrual cramps may find relief in erectile dysfunction drugs

Scientists test affected human nerve cells to foretell efficacy of Alzheimer drugs

NPS MedicineWise publishes set of FAQs on statins and heart disease

Researchers update extensive toxicology database to track information about drugs toxic effects

Revolutionary new treatment for crippling hand conditions

Study reveals that brain cancer cells resist therapy by dialing down gene mutation targeted by drugs

Telomerase inhibiting drug induces morphologic, molecular, clinical remissions in myelofibrosis patients

Combination of preventive and therapeutic moxibustion has beneficial effect for Alzheimer's disease

Study results show insulin sensitizers reduce risk of cancer in female patients with type 2 diabetes

Older people ingest too much magnesium, vitamin E in the form of dietary supplements

Mylan Pharmaceuticals introduces Cabergoline Tablets USP, 0.5 mg

First Databank starts publishing NADAC pricing file released by CMS

EMA expands administration options for Hizentra

IDSA released new guideline for vaccination of immunocompromised hosts

VTT receives innovation prize for technological development work behind allergy vaccine

TB vaccine may help prevent multiple sclerosis

MassBiologics gets FDA orphan drug designation for MBL-HCV1 antibody

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News